StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

Earnings

Coya Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 15, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$200.00K
-94.4% on a year earlier
EPS, Q3 FY2026
-$0.45
-$0.13 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Coya Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 15, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026before the open$200.00K-94.4%-$0.45Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026before the open$200.00K0.0%–Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open$300.00K+16.3%-$0.32Release
Q4 FY2025ended Dec 31, 2025Mar 16, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$3.60M–-$0.13Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025before the open$200.00K-94.1%–Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open$257.88K+103.3%-$0.44Release
Q4 FY2024ended Dec 31, 2024Mar 18, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open$3.40M–-$0.19Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close$126.84K–-$0.35Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Coya Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Coya Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Coya Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Update
  6. Results
  7. Update
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Update
  14. Update
  15. Update

See a number that looks wrong?